Tyler Bussian
Stock Analyst at Brookline Capital
(0.16)
# 3,654
Out of 4,667 analysts
5
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tyler Bussian
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COCH Envoy Medical | Initiates: Buy | $9 | $2.21 | +307.24% | 1 | Oct 14, 2024 | |
| CRVO CervoMed | Initiates: Buy | $63 | $9.50 | +563.16% | 1 | Jul 8, 2024 | |
| IMUX Immunic | Initiates: Buy | $10 | $1.07 | +838.97% | 1 | Apr 5, 2024 | |
| ANVS Annovis Bio | Downgrades: Hold | $9 | $6.62 | +36.03% | 2 | Feb 28, 2024 |
Envoy Medical
Oct 14, 2024
Initiates: Buy
Price Target: $9
Current: $2.21
Upside: +307.24%
CervoMed
Jul 8, 2024
Initiates: Buy
Price Target: $63
Current: $9.50
Upside: +563.16%
Immunic
Apr 5, 2024
Initiates: Buy
Price Target: $10
Current: $1.07
Upside: +838.97%
Annovis Bio
Feb 28, 2024
Downgrades: Hold
Price Target: $9
Current: $6.62
Upside: +36.03%